Rosetta Genomics Ltd. Debt Instrument, Convertible, Beneficial Conversion Feature
Rosetta Genomics Ltd. reported Debt Instrument, Convertible, Beneficial Conversion Feature of -$2.06 million for the 6-month period ending 2012-06-30, per its 6-K filed 2013-09-09.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature · last filed 2013-09-09
- 2012-06-30: Debt Instrument, Convertible, Beneficial Conversion Feature 6 month -$2.06M.
| Period end | Debt Instrument, Convertible, Beneficial Conversion Feature 6 month |
|---|---|
| 2012-06-30 | -$2.06M 6-K · filed 2013-09-09 |